Erenumab - Comprehensive Assessment of Efficacy in (High-Frequency) Episodic Migraine

Summary

The primary objective of this study is to evaluate the treatment benefit of erenumab on headache duration of at least moderate pain intensity.

Timeline

Start

2020-09-15

Primary completion

2023-10-26

Completion

2023-10-26

Publications

• Background Paiva da Silva Lima G, Rao R, Szabo G, Szklener S, Tassorelli C, Nastaj M, Chou DE, Khodavirdi AC, Chehrenama M, Zhu Y, Bhatia AK, Dodick DW. Comprehensive assessment of erenumab efficacy in participants with high-frequency episodic migraine with at least one previously failed preventive treatment: The EMBRACE study. Headache. 2026 Mar;66(3):658-671. doi: 10.1111/head.15071. Epub 2025 Oct 14.

Drugs

Indications